Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes

Diabetes Care. 2007 Apr;30(4):995-6. doi: 10.2337/dc06-2079. Epub 2007 Jan 17.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Creatinine / urine
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / urine*
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / urine*
  • Double-Blind Method
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Indoles / therapeutic use*
  • Maleimides / therapeutic use*
  • Middle Aged
  • Placebos
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C beta
  • Transforming Growth Factor beta / genetics*
  • Transforming Growth Factor beta / urine

Substances

  • Enzyme Inhibitors
  • Indoles
  • Maleimides
  • Placebos
  • Transforming Growth Factor beta
  • ruboxistaurin
  • Creatinine
  • Protein Kinase C
  • Protein Kinase C beta